Progress We proudly keep you up to date about the progress we are making on our roadmap towards enabling Assisted Reproductive Technologies In Space (ARTIS).
Press release to warn space tourism sector for uncontrolled conception in space
From Monday April 24 available for direct download, a press release by Cranfield University, SpaceBorn & ASRI, initiated by Prof. Cullen: ‘Sex in space. Consideration of uncontrolled conception in emerging space tourism.
Click on this link for direct access to the press release.
Interview with Professor David Cullen of Cranfield University
Interview with Prof. David Cullen (full version) about the key challenges of SpaceBorn United's ARTIS missions. David Cullen is Professor of Astrobiology and Space Biotechnology, as part of the Space Group at Cranfield University (UK). David is one of the key advisors of SpaceBorn United, involved with Payload design and mission architecture.
Interview with Dr. Aqeel Shamsul, CEO of Frontier Space Technologies
Frontier Space Technologies is our implementation partner for the design and manufacturing of the ARTIS life support system that will enable conception and early embryo development in space. Dr. Aqeel Shamsul (CEO) explains the challenges it involves to realize the different sub-systems of our IVF-in-space (ARTIS) technology.
Interview with Rapid Fluidics CEO Paul Marshall
Rapid Fluidics is our implementation partner for the design and manufacturing of the microfluidic technology that will enable conception and early embryo development in space. Paul Marshall (CEO) explains the challenges it involves to realize this crucial part of our IVF-in-space (ARTIS) technology.
Upcoming test flight
Our IVF-in-space prototype includes various data collection sensors and is fully prepared for payload integration with selected rocket types. These sensors monitor life support variables like climate controls, flight conditions and micro cameras that monitor individual embryo development. Our prototype will be tested onboard a rocket during sub orbital test flight into space in August 2023.
We achieved an important milestone this year by finalizing our IVF-in-space prototype with our implementation partners. This re-engineered IVF technology is the key payload for our ARTIS missions, enabling conception and embryo development in space. The video’s below shows more details regarding key components of our payload development, mission architecture and the alignment with key implementation partners.